An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer-Reference-Cited by-同舟云学术

An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer

Published:2023-12 Issue: Volume:72 Page:103585
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Lee Anbok,Kang Taewoo,Kang Su Hwan,Park Woo-Chan,Lim Woosung,Chang Myung-Chul,Kim Hyun Yul,Song Jeong-yoon,Lee Jihyoun,Byun Kyung Do,Kim Hyun-Ah,Son Gil Soo,Kim Ju-Yeon,Oh Se Jeong,Chung Min Sung,Choi Young Jin,Shin Hyuk-Jai,Baek Jong Min,Yoo Youngbum,Um Eunhae,Choi Jin Hyuk,Kwak Beom Seok,Park Min Ho,Lee Suok Hyun,Kim Cheol Seung,Lee Ilkyun,Kim Je-Ryong,Lee Han Shin,Lim Cheol Wan

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference29 articles.

1. Clinical impact of primary prophylactic pegfilgrastim in breast cancer patients receiving adjuvant docetaxel-doxorubicin-cyclophosphamide chemotherapy;Jeon;J Breast Cancer,2020

2. Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study;Takashi;Breast,2021

3. Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia;Miguel;Support Care Cancer,2015

4. Pegfilgrastim for primary prophylaxis of febrile neutropenia in breast cancer patients undergoing TAC chemotherapy;Lee;Ann Surg Treat Res,2018

5. Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in breast cancer in the United Kingdom;Whyte;Value Health,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pegfilgrastim;Reactions Weekly;2023-11-11